Chengwu Zeng

20PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMedical infection agents (incl. prions)Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 06, 2025
m6A/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability.

Feng Huang, Yushuai Wang, Xiuxin Zhang

|Nov 25, 2024
Aptamer sgc8-Modified PAMAM Nanoparticles for Targeted siRNA Delivery to Inhibit BCL11B in T-Cell Acute Lymphoblastic Leukemia.

Xiangbo Zeng, Dingrui Nie, Zhen Liu

|May 27, 2024
BET Inhibitor JQ1 Selectively Reduce Tregs by Upregulating STAT3 and Suppressing PD-1 Expression in Patients with Multiple Myeloma.

Youxue Huang, Mengjun Zhong, Rili Gao

|Sep 02, 2023
Higher 13-Gene-Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T-Cell Lymphoma Patients.

Cunte Chen, Ling Huang, Zheng Chen

|Aug 28, 2023
T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.

Cunte Chen, Ling Huang, Sichu Liu

|Jan 28, 2023
High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia.

Xibao Yu, Cunte Chen, Yanyun Hu

Pageof 4

Frequent Collaborators

17 joint publications

Yangqiu Li

13 joint publications

Cunte Chen

3 joint publications

Shaohua Chen

2 joint publications

Peng Li